Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ADX | Common Stock | Award | $10.3K | +709 | +3.53% | $14.55 | 20.8K | Jan 3, 2023 | By Trust | F1, F2, F3 |
transaction | ADX | Common Stock | Award | $12.5K | +865 | +4.02% | $14.46 | 22.4K | Jan 5, 2023 | By Trust | F1, F3, F4 |
holding | ADX | Common Stock | 750 | Jan 3, 2023 | Direct | F5 | |||||
holding | ADX | Common Stock | 2.6K | Jan 3, 2023 | Held By Spouse | F6 |
Kathleen T. Mcgahran is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | Director Retirement |
F2 | Of these shares, 709 accrued as dividend equivalents on 750 deferred stock units granted in 2013 and issued on 01/03/2023 (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $14.36 - $16.07 during the period of January 1, 2023 to April 20, 2023. |
F3 | Kathleen T. McGahran and Myra Koutzen TTEES of the McGahran/Koutzen TR U/A DTD 06/23/2016. |
F4 | Of these shares, 865 accrued as dividend equivalents on 750 deferred stock units granted in 2008 and issued on 01/05/2023 (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $14.36 - $16.07 during the period of January 1, 2023 to April 20, 2023. |
F5 | Deferred Restricted Stock Units |
F6 | Myra Koutzen IRA |